Natco Pharma posts consolidated Q2F Y24 PAT of Rs. 369 Cr

Natco Pharma posts consolidated Q2F Y24 PAT of Rs. 369 Cr

By: IPP Bureau

Last updated : November 15, 2023 2:06 pm



Natco Pharma has reported total income of Rs. 1060.8 crores during the period ended September 30, 2023


Natco Pharma Limited has reported consolidated financial results for the period ended September 30, 2023.

Natco Pharma has posted net profit of Rs. 369 crores for the period ended September 30, 2023 as against net profit of Rs. 420.3 crores for the period ended June 30, 2023. The company posted net profit of Rs.56.8 crores for the period ended September 30, 2022.

Natco Pharma has reported total income of Rs. 1060.8 crores during the period ended September 30, 2023 as compared to Rs. 1160.2 crores during the period ended June 30, 2023. The company reported total income of Rs.452.6 crores during the period ended September 30, 2022.

For the Half Year ended September 30, 2023, Natco Pharma has reported total income of Rs.2221 crores as compared to Rs.1371.5 crores during the 6 Months period ended September 30, 2022.

The company has posted net profit of Rs.789.3 crores for the 6 Months period ended September 30, 2023 as against net profit of Rs.377.2 crores for the 6 Months period ended September 30, 2022.

Natco Pharma

First Published : November 15, 2023 12:00 am